Form 4 for AGL agilon health, inc.
Accepted 2021-09-15 00:00:00 ET · period of report 2021-09-14 · accession 0001209191-21-056204 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-15 | 2021-09-14 | AGL | Mansukani Sharad | Dir | M - OptEx | $1.00 | +156.2K | 1.39M | +13% | +$156.2K |
| D | 2021-09-15 | 2021-09-14 | AGL | Mansukani Sharad | Dir | S - Sale+OE | $28.98 | -156.2K | 1.23M | -11% | -$4.53M |
| D | 2021-09-15 | 2021-09-14 | AGL | Mansukani Sharad | Dir | M - OptEx | $0.00 | -156.2K | 493.8K | -24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-14 | M | A | 156,250 | $1.00 | 1,385,606 | D | — | — | (F1) Includes restricted stock units. |
| 2 | Common | Common Stock | 2021-09-14 | S | D | 156,250 | $28.98 | 1,229,356 | D | — | — | (F1) Includes restricted stock units. |
| 3 | Derivative | Options (Rights to Buy) | 2021-09-14 | M | D | 156,250 | $0.00 | 493,750 | D | $1.00 · — to 2027-04-27 | 156,250 Common Stock | (F2) These options were granted on April 27, 2017, and fully vested on July 1, 2020. |